Five Takeaways on the State of AI in Healthcare from HLTH 2025

Garrett Brown

10/29/2025

Healthcare’s AI Moment is Here—and it’s Operational

HLTH 2025 made one thing unmistakably clear: healthcare’s AI era is no longer about pilots or prototypes—it’s about productivity. Across every panel and conversation, the message was the same: AI is moving from concept to infrastructure. Clinicians, executives, and investors agreed that the technology’s value is finally being realized in measurable, near-term outcomes, from documentation and denials to staffing and scheduling.

1. Ambient Intelligence Is Healthcare’s First Killer App

AI’s first breakout success story isn’t diagnostics or drug discovery—it’s documentation. Across sessions, leaders described how AI scribes have transformed clinical workflows. One health system reported reducing note-taking time by 80% and cutting “pajama time” dramatically after rolling out ambient listening tools across outpatient clinics. Physicians described the impact as “nothing short of magical,” with some even delaying retirement because their jobs became enjoyable again.

The appeal is simple: it delivers immediate ROI without touching the patient directly. AI scribes now handle charting, inbox management, and even coding handoffs. As one executive noted, the adoption curve has been unlike any other health IT initiative: “Most tech takes years to see results. This one took months.”

(HLTH 2025: AI Agent Hot Seat).

2. Distribution, Not Development, Is the New Moat

A consistent undercurrent at HLTH was that the power in healthcare AI is shifting from who builds the model to who gets it adopted. AI’s value now depends less on foundational research and more on distribution—who can embed into existing workflows, scale quickly, and deliver reliability in regulated settings.

Speakers across provider and payer panels described this dynamic. Providers emphasized interoperability and embedding AI inside their EHRs, while payers discussed the need to integrate AI tools directly into utilization management and claims review systems rather than layering them on top (HLTH 2025: Payer–Provider Interactions).

As one panelist put it, the new advantage lies in “who owns the interface between human and machine.” The AI that wins healthcare won’t necessarily be the smartest—it will be the most seamlessly distributed (HLTH 2025: Agentic Giants).

3. The ROI Revolution Is Happening in the Back Office

While generative models dominate headlines, the most significant value creation today is occurring far from the bedside—in coding, billing, and operations.
Executives described how AI-powered systems are already generating measurable returns:

A leading health system now codes 200,000+ inpatient encounters automatically using generative models, with human review layered for safety (HLTH 2025: AI Agent Hot Seat).
Optum’s analytics platform improved OR utilization by 7% through AI scheduling optimization (HLTH 2025: AI Agent Hot Seat).
One payer–provider network achieved a 23% reduction in denials via automated case review (HLTH 2025: AI Agent Hot Seat).

These numbers signal a broader trend: the “boring” applications—revenue cycle, scheduling, staffing, documentation—are producing the fastest ROI and highest satisfaction scores. As one panelist quipped, “AI is finally making the unsexy parts of healthcare profitable.”

4. The Cultural Challenge Outweighs the Technical One

Even as AI delivers results, its biggest obstacle isn’t accuracy—it’s adoption. Nearly every executive stressed that culture, not code, determines success.

“AI accelerates whatever process you have,” said one health system leader. “If your process is broken, it’ll make it worse.” (HLTH 2025: AI Agent Hot Seat). Another added that real transformation requires workflow redesign, not just software deployment. Teams that succeed pair their AI rollout with explicit change management and retraining.

Payers echoed the same theme. In one panel, Cigna’s clinical leaders described using AI for prior authorization but noted that data transparency and physician trust were make-or-break factors. “Technology works,” one said, “but healthcare adoption still happens one workflow at a time.” (HLTH 2025: Payer–Provider Interactions).

5. From Hype to Health—Agentic and Clinical AI Are Taking Shape

If 2024 was the year of generative AI, 2025 is the dawn of agentic and clinical AI—systems that not only reason but act, predict, and personalize. Across HLTH, speakers described a turning point: AI moving from the back office to the bedside.

In the Agentic Giants session, leaders from Google, Microsoft, and OpenAI discussed how autonomous AI “agents” could transform healthcare’s operating system—connecting patient intent to system action (HLTH 2025: Agentic Giants). Panelists referenced OpenAI’s HealthBench, introduced earlier in 2025, as a milestone in defining new standards for evaluating medical models. Microsoft’s Dominic King described agentic AI as “the only plausible bridge across the global clinician shortage.”

But the most significant shift wasn’t theoretical—it was clinical. In women’s health, new RNA and blood-based diagnostics are predicting preeclampsia and preterm birth months before symptoms appear, enabling targeted interventions and lowering NICU admissions (HLTH 2025: Women’s Health Innovation). Health systems are piloting predictive models for sepsis detection and chronic disease management, while AI voice agents now handle up to 60% of patient adherence calls automatically (HLTH 2025: AI Agent Hot Seat).

Together, these advances point toward a new phase of healthcare AI: from administrative augmentation to anticipatory medicine. The tools that once streamlined workflows are beginning to forecast risk, personalize treatment, and extend care capacity—blurring the line between operational efficiency and clinical transformation.

The Bottom Line

HLTH 2025 marked the moment AI in healthcare became both real and relevant. For the first time, operational AI and clinical AI are advancing in parallel—one rewriting the economics of care delivery, the other reshaping its practice.

The conference consensus was clear: the winners of the next decade will be those who can do both—operationalize the ordinary and personalize the extraordinary. AI’s future in healthcare won’t be defined by who builds the flashiest model, but by who can distribute, integrate, and scale intelligence across every layer of care.

Disclaimer

The information contained herein is for informational and educational purposes only, does not constitute an offer to sell or the solicitation of an offer to purchase any security, is not presented with a view to providing investment advice with respect to any security, or making any claim as to the past, current or future performance thereof, and Revelation expressly disclaims the use of this document for such purposes. Each recipient should consult its own advisers as to legal, business, tax and other related matters concerning any investment.

Statements contained herein are based on current expectations, estimates, projections, opinions, views and beliefs of Revelation as of the date of this document. Such statements involve known and unknown risks and uncertainties, and undue reliance should not be placed thereon. Neither Revelation nor any of its affiliates makes any representation or warranty, express or implied, as to the accuracy or completeness of the information contained herein and nothing contained herein should be relied upon as a promise or representation as to past or future performance. Revelation and its members, partners, stockholders, managers, directors, officers, employees and agents do not have any obligation to update any information included herein. Certain information contained herein has been obtained from published and non-published sources and/or prepared by third-parties, and in certain cases has not been updated through the date hereof. While such information is believed to be reliable for the purposes of this document, Revelation assumes no responsibility for the accuracy or completeness of such information and such information has not been independently verified by it. The inclusion of any third-party firm and/or company names, brands and/or logos does not imply any affiliation with these firms or companies. None of these firms or companies have endorsed Revelation or any affiliated entities or personnel. Recipients of this document agree that none of Revelation or its affiliates or its or their respective partners, members, employees, officers, directors, agents, or representatives shall have any liability for any misstatement or omission of fact or any opinion expressed herein.

Certain information contained herein constitutes “forward-looking statements,” which can be identified by the use of terms such as “may,” “will,” “should,” “could,” “would,” “predicts,” “potential,” “continue,” “expects,” “anticipates,” “projects,” “future,” “targets,” “intends,” “plans,” “believes,” “estimates” (or the negatives thereof) or other variations thereon or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, some of which are beyond the control of Revelation. Actual results, performance, prospects or opportunities could differ materially from those expressed in or implied by the forward-looking statements. Additional risks of which Revelation is not currently aware also could cause actual results to differ. In light of these risks, uncertainties and assumptions, recipients should not place undue reliance on any forward-looking statements. The forward-looking events discussed in this document may not occur. Revelation undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. The delivery of this document at any time shall not under any circumstances create an implication that the information contained herein is correct as of any time after the earlier of the relevant date specified herein or the date of this document.